CRIS Current Research Information System

RAVAIOLI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.076
AS - Asia 5.598
EU - Europa 3.766
AF - Africa 433
SA - Sud America 321
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.202
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.012
SG - Singapore 1.936
CN - Cina 1.880
IT - Italia 1.045
GB - Regno Unito 596
VN - Vietnam 532
DE - Germania 510
SE - Svezia 425
HK - Hong Kong 412
IN - India 288
KR - Corea 286
BR - Brasile 232
NL - Olanda 228
IE - Irlanda 169
RU - Federazione Russa 156
CI - Costa d'Avorio 152
FR - Francia 106
SC - Seychelles 104
FI - Finlandia 97
AT - Austria 70
BG - Bulgaria 70
JP - Giappone 66
ZA - Sudafrica 58
CH - Svizzera 57
TG - Togo 56
UA - Ucraina 54
ID - Indonesia 52
NG - Nigeria 41
CA - Canada 37
AR - Argentina 35
EE - Estonia 34
JO - Giordania 27
PL - Polonia 26
ES - Italia 25
BE - Belgio 24
PK - Pakistan 23
EC - Ecuador 22
MX - Messico 19
BD - Bangladesh 15
IQ - Iraq 13
TR - Turchia 12
EG - Egitto 11
IR - Iran 11
PT - Portogallo 11
HR - Croazia 10
LT - Lituania 10
GR - Grecia 9
PY - Paraguay 7
AL - Albania 6
AU - Australia 6
CZ - Repubblica Ceca 6
PE - Perù 6
BA - Bosnia-Erzegovina 5
CL - Cile 5
CO - Colombia 5
RS - Serbia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
KZ - Kazakistan 4
LB - Libano 4
PH - Filippine 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
MK - Macedonia 3
MY - Malesia 3
TH - Thailandia 3
BO - Bolivia 2
DZ - Algeria 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
MN - Mongolia 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GI - Gibilterra 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 16.202
Salva come PNG Salva come JPEG
Città #
Singapore 1.323
Ashburn 806
Fairfield 781
Hefei 622
Southend 503
Chandler 415
Hong Kong 406
Seoul 280
Bologna 270
Santa Clara 227
Beijing 223
Seattle 222
Woodbridge 217
New York 200
Houston 184
Wilmington 183
Boardman 173
Cambridge 172
Dublin 169
Princeton 156
Abidjan 152
Dallas 134
Ho Chi Minh City 134
Ann Arbor 125
Los Angeles 111
Milan 102
Hanoi 101
Munich 68
Sofia 68
Dong Ket 62
Bengaluru 58
Tokyo 58
Las Vegas 57
Buffalo 56
Lomé 56
Redondo Beach 54
Frankfurt am Main 50
Nanjing 48
Helsinki 46
Redmond 46
Vienna 46
Turin 43
Westminster 43
Berlin 40
Bremen 39
Abeokuta 38
Bern 37
Florence 37
Rome 37
North Charleston 36
San Diego 36
São Paulo 36
Council Bluffs 34
Guangzhou 33
Medford 31
Brooklyn 30
Shanghai 30
Des Moines 29
Redwood City 29
Turku 29
Jakarta 28
Amman 27
Boydton 26
Dearborn 25
Brussels 24
Falkenstein 24
Jinan 23
Tongling 22
Hyderabad 21
Lappeenranta 20
Nuremberg 20
London 19
Phoenix 19
Washington 19
Chicago 18
Padova 18
Saint Petersburg 18
Warsaw 18
Changsha 17
San Francisco 17
Shenyang 17
Haiphong 16
Tianjin 16
Düsseldorf 15
Stockholm 15
Amsterdam 14
Denver 14
Falls Church 14
Hangzhou 14
Nanchang 14
Wuhan 13
Zhengzhou 13
Bari 12
Chengdu 12
Jiaxing 12
Shenzhen 12
The Dalles 12
Xi'an 12
Yubileyny 12
Biên Hòa 10
Totale 10.523
Salva come PNG Salva come JPEG
Nome #
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 251
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 247
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 238
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests 234
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 215
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis 195
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 194
Monofocal hepatocellular carcinoma: How much does size matter? 190
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 190
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 189
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 189
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 185
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 185
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 182
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 180
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 179
An all-natural, very low-calorie ketogenic diet (VLCKD) protocol has similar efficacy and safety to commercial meal replacements (whole or partial) in inducing weight loss: results from a prospective, controlled, 4-arm pragmatic trial (KOBE trial) 175
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 169
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 168
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 164
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 162
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 161
Gut Microbiota and Celiac Disease 159
Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness 159
IL28 polymorphism and HCC after DAAs for chronic hepatitis C 159
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 159
Pattern of macrovascular invasion in hepatocellular carcinoma 159
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 158
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 156
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 155
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 154
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 154
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 148
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 146
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 146
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 145
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 143
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 142
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 141
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 140
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 140
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c 140
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 139
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 139
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 139
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 139
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study 131
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C 130
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 129
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives 128
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 128
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 128
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 127
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 125
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 125
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 125
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 125
Is Ultrasound Elastography Useful in Predicting Clinically Relevant Pancreatic Fistula After Pancreatic Resection?: A Systematic Review and Meta-analysis 124
Comparison of screening strategies with two new tests to score and diagnose varices needing treatment 123
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 121
Liver Measurement Stiffness Can Predict Chemotherapy-related Liver Injury and Complications after Surgery for Liver Metastases 119
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 119
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 117
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma 117
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 116
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 116
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 115
null 115
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 115
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 114
Intestinal failure associated liver disease after weaning off home parenteral nutrition: a 12-month follow up 113
Spleen stiffness by ultrasound elastography 113
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 113
The changing scenario of hepatocellular carcinoma in Italy: an update 112
Transition of patients with chronic intestinal failure from paediatric to adult center 111
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients 111
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 109
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 109
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 108
Malnutrition in hospitalized patients with SARS-CoV-2 infection 107
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection 107
Non-invasive tests for the prediction of primary hepatocellular carcinoma 107
Prediction of posthepatectomy liver failure: Role of SSM and LSPS 106
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients- UEG Week 2020 Poster Presentations 104
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 103
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 103
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study 102
THU-086 - The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients 102
Longitudinal evaluation of liver stiffness in three pediatric patients with veno-occlusive disease 102
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 102
Editorial: collagen proportionate area as a prognostic indicator in NAFLD 101
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 101
Metformin and the Liver: Unlocking the Full Therapeutic Potential 101
Pancreatic ultrasound elastography is not useful to predict the risk of pancreatic fistulas after pancreatic resection 100
New insights on portal hypertension's screening in people with cystic fibrosis 97
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 97
Small bites, big impact: The importance of evening snacks in patients with advanced chronic liver disease 96
Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility 95
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis 95
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 93
Totale 13.853
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021665 0 0 0 0 0 30 61 91 128 74 40 241
2021/20222.004 59 43 61 85 173 81 60 109 128 112 836 257
2022/20232.037 157 227 91 263 150 173 83 80 387 71 212 143
2023/2024958 61 134 72 75 92 241 33 65 53 66 36 30
2024/20253.616 134 421 363 243 411 166 284 150 70 352 287 735
2025/20265.191 963 1.223 955 846 784 420 0 0 0 0 0 0
Totale 16.588